Background Image
Previous Page  28 / 84 Next Page
Information
Show Menu
Previous Page 28 / 84 Next Page
Page Background

28

We believe our compensation of our NEOs aligns well with our performance, but we also believe

that this alignment is not always reflected in the Summary Compensation Table in the same way we

view the alignment for our internal purposes. This is because the Summary Compensation Table values

are required by Securities and Exchange Commission rules to include the full grant date fair value of

equity awards in the year the awards are granted. The grant date fair value is an accounting value that

projects the potential value of awards based on assumptions about, among other things, certain future

events. The grant date fair value is different from the economic value of the awards to our NEOs, which

may be lower or higher than the grant date fair value depending on the price of our common stock. For

this reason, we are including in this proxy statement, as a supplement to the required Summary

Compensation Table, a comparison of our NEOs’ realizable pay for 2014 with their total compensation

as shown in the Summary Compensation Table.

Name and Principal Position

Summary

Compensation

Table Total

Compensation ($)

Total Realizable

Compensation ($)

Mark J. Gliebe

Chairman and Chief Executive Officer

7,145,715

5,016,695

Charles A. Hinrichs

Vice President and Chief Financial Officer

1,543,052

1,057,941

Jonathan J. Schlemmer

Chief Operating Officer

1,923,401

1,357,582

Peter C. Underwood

Vice President, General Counsel and Secretary

1,144,293

790,618

Terry R. Colvin

Vice President, Corporate Human Resources

752,272

669,939

The realizable pay disclosure in the table above is the same as the compensation shown in the

Summary Compensation Table except that it values equity‐based compensation based on the price of

our common stock at fiscal year end. Restricted stock units (“RSUs”) are valued as the product of the

number of shares granted to the officer during the year multiplied by the year‐end stock price, assuming

for purposes of this disclosure that the grants were vested. Stock appreciation rights (“SARs”) are

valued as the product of the number of rights granted to the officer during the year multiplied by the

excess, if any, of the year‐end stock price over the grant price of the rights, assuming for purposes of this

disclosure that the grants were vested. In addition, the performance share units (“PSUs”) granted to the

NEOs in 2014 have been valued using 32% of the target number of shares under the grants (which is

approximately the number of shares that would vest if the company’s total relative total shareholder

return for the entire applicable performance period is the same as it was for 2014), multiplied by the

year‐end stock price.

To illustrate how the compensation of our CEO has aligned with our total shareholder return, we

are also including the following supplemental graph, which compares our total shareholder return with